SACRAMENTO, California — California will start selling low-cost insulin in January, becoming the first state in the nation to ...
Speaking to reporters on the sidelines of Wednesday’s Cabinet session, Mohajerani said the administration and the diplomatic apparatus have exerted all efforts to prevent the activation of the ...
A research team has resolved a 50-year-old controversy in neuroscience. By employing a self-developed, time-resolved ...
Race identifies primary mechanism of action for (E,E)-bisantrene (RCDS1), the active compound underpinning its lead candidate RC220 drug Targeting G4-DNA and RNA structures by RCDS1 reduces the ...
Meta Platforms Inc. is set to face a charge sheet from the European Union for failing to adequately police illegal content, risking fines for violating the bloc’s content moderation rulebook. The ...
Diabetes mellitus, encompassing both Type 1 (T1D) and Type 2 diabetes (T2D), threatens human health on a global scale. Diabetes affects individuals of all ...
Civica announced today that it plans to launch an affordable long-acting insulin in pre-filled pens starting in January 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback